Barr earnings rise on strength of products

August

Barr Pharmaceuticals Inc., the drug company that has operations in Pomona, earned $57 million, or 52 cents a share, in the second quarter, compared with a profit of $45 million, or 41 cents a share, a year earlier.

Revenues rose to $779 million, from $634 million.

Barr, which is based in Montvale, N.J., has its Barr Laboratories Inc. subsidiary in Pomona.

But the future of the Pomona site is in question after the company announced last month that it plans to be acquired by Israeli manufacturer Teva Pharmaceutical Industries Ltd., the world’s largest maker of generic drugs, for stock and cash. The deal values Barr at $66.50 a share.

Teva will pay $7.46 billion and assume $1.5 billion in Barr debt.

Barr shares closed at $66.97 yesterday, up 13 cents.

This entry was posted on Thursday, August 7th, 2008 at 9:37 am by Allan Drury.
You can follow any responses to this entry through the RSS 2.0 feed.
Share and Enjoy: | Print Print | Email Email

It is a condition of your use of the comment features associated with the blogs that you do not: Use the site to post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including without limitation any transmissions constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or international law. You alone are responsible for the material you post or send. Refer to the Terms of Service.

Business in the Burbs

Movers, shakers and newsmakers